SecSonar.com

IGC Pharma, Inc. (IGC)

IGC Pharma, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

IGC Pharma, Inc. (IGC) is a Biotechnology company based in US with a market capitalization of $28.7M. Revenue declined 6.7% year-over-year and free cash flow was negative at -$6.1M. This page tracks IGC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 67 employees · IPO May 24, 2006

Valuation

Valuation & price

$0.29 · as of May 17, 2026 · -39.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

4.69

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$0.47$0.36$0.25Jul 25Dec 25Jul 26Jul 7, 25$0.32Jul 9, 25$0.37Jul 11, 25$0.38Jul 15, 25$0.34Jul 17, 25$0.34Jul 21, 25$0.37Jul 23, 25$0.40Jul 25, 25$0.37Jul 29, 25$0.37Jul 31, 25$0.36Aug 4, 25$0.35Aug 6, 25$0.34Aug 11, 25$0.35Aug 13, 25$0.36Aug 15, 25$0.37Aug 19, 25$0.37Aug 21, 25$0.35Aug 25, 25$0.37Aug 27, 25$0.45Aug 29, 25$0.43Sep 3, 25$0.47Sep 5, 25$0.43Sep 9, 25$0.42Sep 11, 25$0.40Sep 16, 25$0.43Sep 18, 25$0.41Sep 22, 25$0.40Sep 24, 25$0.41Sep 26, 25$0.40Sep 30, 25$0.42Oct 2, 25$0.40Oct 6, 25$0.41Oct 8, 25$0.42Oct 10, 25$0.40Oct 14, 25$0.42Oct 16, 25$0.40Oct 21, 25$0.39Oct 23, 25$0.38Oct 27, 25$0.42Oct 29, 25$0.40Oct 31, 25$0.40Nov 4, 25$0.39Nov 6, 25$0.39Nov 10, 25$0.38Nov 12, 25$0.37Nov 14, 25$0.36Nov 18, 25$0.34Nov 20, 25$0.31Nov 25, 25$0.32Nov 28, 25$0.32Dec 2, 25$0.31Dec 4, 25$0.31Dec 8, 25$0.29Dec 10, 25$0.34Dec 12, 25$0.35Dec 16, 25$0.34Dec 18, 25$0.34Dec 22, 25$0.31Dec 24, 25$0.30Dec 29, 25$0.30Jan 2, 26$0.29Jan 6, 26$0.29Jan 8, 26$0.30Jan 12, 26$0.30Jan 14, 26$0.30Jan 16, 26$0.30Jan 21, 26$0.28Jan 23, 26$0.29Jan 27, 26$0.29Jan 29, 26$0.28Feb 2, 26$0.27Feb 4, 26$0.26Feb 9, 26$0.25Feb 11, 26$0.25Feb 13, 26$0.26Feb 18, 26$0.25Feb 20, 26$0.26Feb 24, 26$0.28Feb 26, 26$0.28Mar 2, 26$0.27Mar 4, 26$0.29Mar 6, 26$0.29Mar 10, 26$0.28Mar 12, 26$0.28Mar 17, 26$0.29Mar 19, 26$0.27Mar 23, 26$0.28Mar 25, 26$0.26Mar 27, 26$0.26Mar 31, 26$0.26Apr 2, 26$0.27Apr 7, 26$0.27Apr 9, 26$0.30Apr 13, 26$0.30Apr 15, 26$0.32Apr 17, 26$0.34Apr 22, 26$0.35Apr 24, 26$0.34Apr 28, 26$0.31Apr 30, 26$0.32May 4, 26$0.32May 6, 26$0.32May 8, 26$0.31May 12, 26$0.30May 14, 26$0.30May 18, 26$0.29May 20, 26$0.28May 22, 26$0.29May 28, 26$0.29Jun 1, 26$0.29Jun 3, 26$0.30Jun 5, 26$0.29Jun 9, 26$0.28Jun 11, 26$0.28Jun 15, 26$0.28Jun 17, 26$0.28Jun 22, 26$0.27Jun 24, 26$0.27Jun 26, 26$0.26Jul 2, 26$0.28
$0.2552-week range$0.47
Loading valuation history…

Fundamentals

Key fundamentals

$28.7M

Market cap

-6.7%

Revenue growth (YoY)

29.7%

Gross margin

-$6.1M

Free cash flow (USD)

-$207K

Net debt

Net cash position

24.2%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2026

FY 2017$580.4KFY 2018$2.2MFY 2019$5.1MFY 2020$4.1MFY 2021$898.0KFY 2022$397.0KFY 2023$911.0KFY 2024$1.3MFY 2025$1.3MFY 2026$1.2M
$580.4K$1.2M

Free cash flow by year

2017 → 2026

FY 2017$-1.5MFY 2018$-2.1MFY 2019$-3.4MFY 2020$-13.1MFY 2021$-12.4MFY 2022$-8.2MFY 2023$-7.7MFY 2024$-5.7MFY 2025$-5.3MFY 2026$-6.1M
-$1.5M-$6.1M

Gross margin by year

2022 → 2026

FY 202248.9%FY 2023-17.3%FY 202454.5%FY 202548.7%FY 202629.7%
48.9%29.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 26, 2026 (EPS $-0.02)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventLoan Agreement ExtensionJun 8, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing
  • 8-K eventDebt FinancingApr 20, 2026Filing

Questions

Frequently asked questions

What is IGC Pharma, Inc.'s market cap?

IGC Pharma, Inc. (IGC) has a market capitalization of $28.7M.

What is IGC's P/E ratio?

A meaningful P/E ratio is not available for IGC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is IGC's price-to-book (P/B) ratio?

IGC trades at 4.69 times book value per share.

When did IGC Pharma, Inc. last report earnings?

IGC last reported earnings on June 26, 2026; the next date is not yet scheduled.

Are insiders buying IGC stock?

SEC Form 4 filings show no open-market insider buys at IGC Pharma, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

LSTA

Lisata Therapeutics, Inc.

$28.8M

BRNS

Barinthus Biotherapeutics plc

$27.9M

DYAI

Dyadic International, Inc.

$27.9M

OTLK

Outlook Therapeutics, Inc.

$30M

IBIO

iBio, Inc.

$30.2M

TVRD

Tvardi Therapeutics, Inc.

$31.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.